N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients

Clinical trial NCT00780962 · COMPLETED

Trial details

NCT number: NCT00780962
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Radiocontrast Nephropathy

Start date: 2007-10-16
Primary completion: 2010-08-09
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.